Citadel Advisors LLC Makes New Investment in Franklin Genomic Advancements ETF (BATS:HELX)
Citadel Advisors LLC acquired a new position in shares of Franklin Genomic Advancements ETF (BATS:HELX – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 7,966 shares of the company’s stock, valued at approximately $230,000. A number of other hedge funds and other institutional investors have also recently added to or […]
